Please login to the form below

Not currently logged in
Email:
Password:

David Haslam

This page shows the latest David Haslam news and features for those working in and with pharma, biotech and healthcare.

NHS England proposes handing CDF remit to NICE

NHS England proposes handing CDF remit to NICE

In fact, NICE argued the same in a parliamentary hearing in September last year after its chairman Professor David Haslam said that NHS England should be using its processes to assess

Latest news

  • WHO: Medicine costs ‘too high’ for European governments WHO: Medicine costs ‘too high’ for European governments

    This echoes the belief of Professor David Haslam, chair of England's health technology assessor NICE, who last year said pharma had to “show its working” on how it came to

  • NICE wants greater access to clinical data NICE wants greater access to clinical data

    The announcement comes a week after NICE's chair Prof David Haslam (pictured right) told a House of Commons health select committee that pharma companies had a “moral imperative” to publish ... Prof Haslam's colleague Prof Carole Longson, who is

  • Public advises NICE on value of care Public advises NICE on value of care

    Healthcare priorities included justice and respect. NICE chairman Professor David Haslam welcomed the draft report, adding that its conclusions will inform the update of the NICE societal value judgements document.

  • UK NHS needs to rethink long-term care UK NHS needs to rethink long-term care

    According to the Committee, these multimorbidities are not adequately recognised in a system set up to address single diseases – a thought backed up by David Haslam, chair of NICE.

  • Fox Communications leads comms for UK obesity week Fox Communications leads comms for UK obesity week

    We have been delighted with the materials created by Fox for what is a very important campaign,” said National Obesity Forum chairman Professor David Haslam.

More from news
Approximately 1 fully matching, plus 8 partially matching documents found.

Latest Intelligence

  • The death of the cancer drugs fund? The death of the cancer drugs fund?

    In fact, NICE argued the same in a parliamentary hearing in September last year after its chairman Professor David Haslam said that NHS England should be using its processes to assess

  • Interview: David Haslam, NICE Interview: David Haslam, NICE

    His replacement, Professor David Haslam, is more than capable of filling those shoes, however, boasting extensive and impressive experience in UK healthcare that includes 35 years as a GP and stints ... A new aspect that Prof Haslam has yet to face in

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

  • David Haslam takes over as NICE chair David Haslam takes over as NICE chair

    Professor David Haslam has taken over as chair of NICE on the same day it changed its name from the National Institute for Health and Clinical Excellence to the National Institute ... Sir Andrew Dillon, NICE's chief executive, said: “We are delighted

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Swordfish Advertising

At Swordfish Advertising, we believe building an effective brand shouldn't be stressful. Don't get us wrong; it takes blood, sweat...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics